Literature DB >> 11027622

Cloning, characterization, and tissue distribution of mouse phosphodiesterase 7A1.

P Wang1, P Wu, R W Egan, M M Billah.   

Abstract

We have cloned a cDNA representing mouse phosphodiesterases (PDE) 7A1. The open reading frame encodes a protein of 482 amino acids with a predicted molecular mass of 55417. Like human PDE7A variants, mouse PDE7A1 and A2 are 5' splice variants from a common gene. The distinct N-terminal sequence of mouse PDE7A1 is highly homologous to the corresponding sequence of human PDE7A1 with a similarity of 98% but not to that of mouse PDE7A2 (with a similarity of 12%), and is more hydrophilic than that of mouse PDE7A2. Mouse PDE7A1 expressed in SF9 cells has been compared with human PDE7A1 under identical conditions. Mouse PDE7A1 has a Km for cAMP of 0.2 microM, an optimal pH of 7.5, an IC(50) value of 14 microM for 3-isobutyl-1-methylxanthine (IBMX), and is dependent on Mg(2+) for activity. All these characteristics are very similar to those of human PDE7A1. In mice, PDE7A1 is expressed in tissues of the immune system (lymph node, thymus, spleen, and blood leukocyte), testis, brain, kidney and lung but not in skeletal muscle, heart, embryo, or liver, while PDE7A2 is expressed in skeletal muscle, heart, embryo, and kidney, but not in the other tissues. This tissue distribution profile is very similar to that in humans, and hence suggests that PDE7A1 and 7A2 might play a similar role in different species. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027622     DOI: 10.1006/bbrc.2000.3613

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

2.  Which phosphodiesterase can decrease cardiac effects of 5-HT4 receptor activation in transgenic mice?

Authors:  Joachim Neumann; Benedikt Käufler; Ulrich Gergs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-04-24       Impact factor: 3.000

3.  Functional characterization of the human phosphodiesterase 7A1 promoter.

Authors:  Mònica Torras-Llort; Fernando Azorín
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

4.  Identification of genes in thyrocytes regulated by unfolded protein response by using disulfide bond reducing agent of dithiothreitol.

Authors:  S Park; I Hwang; M Shong; O Y Kwon
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

Review 5.  The Role of PDE8 in T Cell Recruitment and Function in Inflammation.

Authors:  Paul M Epstein; Chaitali Basole; Stefan Brocke
Journal:  Front Cell Dev Biol       Date:  2021-04-16

6.  Synthesis, structural analysis, and biological evaluation of thioxoquinazoline derivatives as phosphodiesterase 7 inhibitors.

Authors:  Tania Castaño; Huanchen Wang; Nuria E Campillo; Sara Ballester; Coral González-García; Javier Hernández; Concepción Pérez; Jimena Cuenca; Ana Pérez-Castillo; Ana Martínez; Oscar Huertas; José Luis Gelpí; F Javier Luque; Hengming Ke; Carmen Gil
Journal:  ChemMedChem       Date:  2009-05       Impact factor: 3.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.